Monash Health, BioQ Devices and QHeart Medical today announced the commencement of pilot clinical testing using the BIOQ CA device
Share Article
Monash Health, BioQ Devices and QHeart Medical today announced the commencement of pilot clinical testing using the BIOQ CA device, a revolutionary “pumpless” heart therapy device for hypertensive heart failure and resistant hypertension.
The BIOQ CA revolutionary “pumpless” heart therapy device for hypertensive heart failure and resistant hypertension has achieved successful results in a world-first clinical study BRISBANE, Australia and MELBOURNE, Australia (PRWEB) May 14, 2021 Monash Health, BioQ Devices and QHeart Medical today announced the commencement of pilot clinical testing using the BIOQ CA device, a revolutionary “pumpless” heart therapy device for hypertensive heart failure and resistant hypertension.